title: Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.
abstract: Atrial fibrillation (AF) is a major cause of ischemic stroke, especially in the elderly. There are currently enough data to support the notion that anticoagulation with warfarin or dabigatran is far superior to aspirin in the prevention of stroke or systemic embolism in AF. Aspirin is the preferred modality in patients who are either not candidates for anticoagulation, such as patients with increased risk for bleeding, low-risk patients based on the CHADS2 score or patients who have difficulty in maintaining a therapeutic international normalized ratio. There is no dispute on the recommendations regarding stroke prevention in high-risk patients (CHADS2 risk score of 2 and beyond) with AF. However, there is some controversy regarding the appropriate strategy (anticoagulation vs aspirin) for stroke prevention in low-risk patients (CHA2DS2-VASc score of 0-1). Novel oral anticoagulant drugs (direct thrombin inhibitors and Factor Xa inhibitors) might further diminish the role of aspirin for stroke prevention in AF due to their superior efficacy, lack of need for monitoring of therapeutic effects and lower bleeding risk when compared with warfarin, especially in patients with stable vascular disease.
authors.affiliation: Department of Medicine, University of Wisconsin School of Medicine and Public Health, 3116 MFCB, 1685 Highland Avenue, Madison, WI 53705, USA. mturagam@medicine.wisc.edu
authors.forename: Mohit K
authors.initials: MK
authors.lastname: Turagam
authors.forename: Poonam
authors.initials: P
authors.lastname: Velagapudi
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Leal
authors.forename: Abraham G
authors.initials: AG
authors.lastname: Kocheril
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D017408:Guidelines as Topic; D006801:Humans; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014652:Vascular Diseases / Q000150:complications*
chemical_list: D000925:Anticoagulants; D001241:Aspirin